Celldex Therapeutics
CLDX
CLDX
179 hedge funds and large institutions have $1.75B invested in Celldex Therapeutics in 2021 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.27% more ownership
Funds ownership: 92.5% → 98.77% (+6.3%)
24% less capital invested
Capital invested by funds: $2.3B → $1.75B (-$545M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
179
Holding in Top 10
7
Calls
$95.1M
Puts
$43M
Top Buyers
| 1 | +$53.5M | |
| 2 | +$22.9M | |
| 3 | +$19.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.1M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$10M |
Top Sellers
| 1 | -$33.9M | |
| 2 | -$14.7M | |
| 3 | -$13.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$12.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.6M |